» Authors » Pierre-Yves Le Roux

Pierre-Yves Le Roux

Explore the profile of Pierre-Yves Le Roux including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 872
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Blanc-Beguin F, Damien P, Floch R, Kerleguer K, Hennebicq S, Robin P, et al.
Front Med (Lausanne) . 2022 Dec; 9:1051249. PMID: 36530884
Introduction: Ventilation/Perfusion (V/Q) PET/CT is an emerging imaging modality for regional lung function evaluation. The same carrier molecules as conventional V/Q scintigraphy are used but they are radiolabelled with gallium-68...
12.
Le Roux P, Schafer W, Blanc-Beguin F, Tulchinsky M
Clin Nucl Med . 2022 Oct; 48(1):8-17. PMID: 36288606
Invented and first approved for clinical use in Australia 36 years ago, Technegas is the technology that enabled ventilation scintigraphy with 99m Tc-labeled carbon nanoparticles ( 99m Tc-CNP). The US...
13.
Fauche A, Presles E, Sanchez O, Jais X, Le Mao R, Robin P, et al.
J Thromb Haemost . 2022 Aug; 20(12):2850-2861. PMID: 36017744
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening complication of a pulmonary embolism (PE) whose incidence and predictors are not precisely determined. Objective: To determine the frequency and predictors...
14.
Noumegni S, Didier R, Mansourati V, Le Moigne E, Le Mao R, Hoffmann C, et al.
Semin Thromb Hemost . 2022 Jun; 48(4):465-480. PMID: 35772402
Background:  There is an increased risk of arterial events including major adverse cardiovascular events (MACE) and major adverse limb events (MALE) after venous thromboembolism (VTE). However, their risk factors remain...
15.
Blanc-Beguin F, Hennebicq S, Robin P, Tripier R, Salaun P, Le Roux P
Pharmaceuticals (Basel) . 2022 May; 15(5). PMID: 35631345
Lung ventilation/perfusion (V/Q) positron emission tomography-computed tomography (PET/CT) is a promising imaging modality for regional lung function assessment. The same carrier molecules as a conventional V/Q scan (i.e., carbon nanoparticles...
16.
Bonnefoy P, Bahloul A, Denizot B, Barres B, Moreau-Triby C, Girma A, et al.
Clin Nucl Med . 2022 May; 47(8):e540-e547. PMID: 35605049
Purpose: In coronavirus disease 2019 (COVID-19) patients, clinical manifestations as well as chest CT lesions are variable. Lung scintigraphy allows to assess and compare the regional distribution of ventilation and...
17.
Li Z, Le Roux P, Callahan J, Hardcastle N, Hofman M, Siva S, et al.
Phys Imaging Radiat Oncol . 2022 Apr; 22:8-12. PMID: 35465222
Pulmonary functional imaging has demonstrated potential to improve thoracic radiotherapy. The purpose of this study was twofold: 1) to quantify ventilation/perfusion relationships in lung cancer patients using a new functional...
18.
Lombion N, Robin P, Tempescul A, Le Roux P, Schick U, Guillerm G, et al.
Q J Nucl Med Mol Imaging . 2022 Feb; 65(4):402-409. PMID: 35133099
Background: Advanced age is an independent poor prognostic factor of diffuse large B-cell lymphoma (DLBCL). PMitCEBO (mitoxantrone, cyclophosphamide, etoposide, vincristine, bleomycin, and prednisolone) is an alternative to the cyclophosphamide, doxorubicin,...
19.
Dissaux B, Le Floch P, Le Pennec R, Tromeur C, Le Roux P
Tomography . 2022 Jan; 8(1):175-179. PMID: 35076610
In this report, we describe the functional imaging findings of systemic artery to pulmonary artery shunt in V/Q SPECT CT imaging. A 63-year-old man with small-cell lung cancer underwent CT...
20.
Le Roux P, Bonnefoy P, Bahloul A, Denizot B, Barres B, Moreau-Triby C, et al.
J Nucl Med . 2021 Oct; 63(7):1070-1074. PMID: 34649944
In patients with novel coronavirus disease 2019 (COVID-19) referred for lung scintigraphy because of suspected pulmonary embolism (PE), there has been an ongoing debate within the nuclear medicine community as...